MHRA Drug Safety Update November 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 4 November 2022) has been published and includes articles on:

  • Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management
  • Consultation with healthcare professionals: please complete our consultation to help influence how we communicate with you
  • COVID-19 vaccines and medicines: updates for November 2022
  • Letters and medicine recalls sent to healthcare professionals in October 2022

To see the latest MHRA Drug Safety Updates in full, visit the website.

Support the call for more funding by recording the informal advice you provide over just one day.

Click Here